BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15852431)

  • 1. ALK-positive diffuse large B-cell lymphoma.
    Bubała H; Małdyk J; Włodarska I; Sońta-Jakimczyk D; Szczepański T
    Pediatr Blood Cancer; 2006 May; 46(5):649-53. PubMed ID: 15852431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK-positive diffuse large B-cell lymphoma: two more cases and a brief literature review.
    Rudzki Z; Rucińska M; Jurczak W; Skotnicki AB; Maramorosz-Kurianowicz M; Mruk A; Piróg K; Utych G; Bodzioch P; Srebro-Stariczyk M; Włodarska I; Stachura J
    Pol J Pathol; 2005; 56(1):37-45. PubMed ID: 15921012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).
    Chikatsu N; Kojima H; Suzukawa K; Shinagawa A; Nagasawa T; Ozawa H; Yamashita Y; Mori N
    Mod Pathol; 2003 Aug; 16(8):828-32. PubMed ID: 12920229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.
    Momose S; Tamaru J; Kishi H; Mikata I; Mori M; Toyozumi Y; Itoyama S
    Hum Pathol; 2009 Jan; 40(1):75-82. PubMed ID: 18755494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3' ALK gene insertion to chromosome 4 q22-24.
    Stachurski D; Miron PM; Al-Homsi S; Hutchinson L; Harris NL; Woda B; Wang SA
    Hum Pathol; 2007 Jun; 38(6):940-5. PubMed ID: 17509395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric ALK+ anaplastic large cell lymphoma with t(3;8)(q26.2;q24) translocation and c-myc rearrangement terminating in a leukemic phase.
    Monaco S; Tsao L; Murty VV; Nandula SV; Donovan V; Oesterheld J; Bhagat G; Alobeid B
    Am J Hematol; 2007 Jan; 82(1):59-64. PubMed ID: 16955462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK-positive diffuse large B-cell lymphoma: report of three cases.
    Lee HW; Kim K; Kim W; Ko YH
    Hematol Oncol; 2008 Jun; 26(2):108-13. PubMed ID: 18220322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.
    Laurent C; Do C; Gascoyne RD; Lamant L; Ysebaert L; Laurent G; Delsol G; Brousset P
    J Clin Oncol; 2009 Sep; 27(25):4211-6. PubMed ID: 19636007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature.
    Grewal JS; Smith LB; Winegarden JD; Krauss JC; Tworek JA; Schnitzer B
    Ann Hematol; 2007 Jul; 86(7):499-508. PubMed ID: 17396261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements.
    Shi M; Miron PM; Hutchinson L; Woda BA; Nath R; Cerny J; Yu H
    Hum Pathol; 2011 Oct; 42(10):1562-7. PubMed ID: 21497367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases.
    Gascoyne RD; Lamant L; Martin-Subero JI; Lestou VS; Harris NL; Müller-Hermelink HK; Seymour JF; Campbell LJ; Horsman DE; Auvigne I; Espinos E; Siebert R; Delsol G
    Blood; 2003 Oct; 102(7):2568-73. PubMed ID: 12763927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisation: a genetic and pathological correlation.
    Perkins SL; Pickering D; Lowe EJ; Zwick D; Abromowitch M; Davenport G; Cairo MS; Sanger WG
    Br J Haematol; 2005 Dec; 131(5):624-7. PubMed ID: 16351638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults.
    Dave BJ; Weisenburger DD; Higgins CM; Pickering DL; Hess MM; Chan WC; Sanger WG
    Cancer Genet Cytogenet; 2004 Sep; 153(2):115-21. PubMed ID: 15350300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital plasmablastic lymphoma--comparison of a newly reported entity with diffuse large B-cell lymphoma of the orbit.
    Morley AM; Verity DH; Meligonis G; Rose GE
    Orbit; 2009; 28(6):425-9. PubMed ID: 19929677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myeloid leukemia as a secondary malignancy after ALK-positive anaplastic large cell lymphoma.
    Alsop S; Sanger WG; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2007 Oct; 38(10):1576-80. PubMed ID: 17889677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
    Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
    Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytomorphology and molecular characterization of CLTC-ALK rearrangement in 2 cases of ALK-positive diffuse large B-cell lymphoma with extensive bone marrow involvement].
    Choung HS; Kim HJ; Kim WS; Kim K; Kim SH
    Korean J Lab Med; 2008 Apr; 28(2):89-94. PubMed ID: 18458503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALK-positive plasmablastic B-cell lymphoma with the clathrin-ALK gene rearrangement.
    Isimbaldi G; Bandiera L; d'Amore ES; Conter V; Milani M; Mussolin L; Rosolen A
    Pediatr Blood Cancer; 2006 Mar; 46(3):390-1. PubMed ID: 16086416
    [No Abstract]   [Full Text] [Related]  

  • 19. Diffuse large B-cell lymphoma with fibrillary matrix.
    Dargent JL; Meiers I; Lespagnard L; Ma Y; Dehou MF; Verhest A
    Diagn Cytopathol; 2002 Oct; 27(4):223-6. PubMed ID: 12357500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma.
    Espinosa I; Briones J; Bordes R; Brunet S; Martino R; Sureda A; Prat J; Sierra J
    Ann Hematol; 2006 Sep; 85(9):597-603. PubMed ID: 16830142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.